Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline - Wikidata - wikimedia - TriplyDB

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

http://www.wikidata.org/entity/Q33763941

about

Psychiatric symptoms in glioma patients: from diagnosis to management.Collaboration in the presence of cerebral edema: The complications of steroids.Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901.Bevacizumab and Temozolomide Plus Radiation Regimen for Glioblastoma Multiforme.TERT rs2853676 polymorphisms correlate with glioma prognosis in Chinese population.Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro.Corticosteroid use in neuro-oncology: an update.The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors.Clinical Relevance of Steroid Use in Neuro-Oncology.The Process and Regulatory Components of Inflammation in Brain Oncogenesis.Corticosteroids compromise survival in glioblastoma.Impact of dexamethasone in patients with aneurysmal subarachnoid haemorrhage.ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior.Corticosteroids for peritumoral edema: time to overcome our addiction?Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay Immunotherapy for brain tumors: understanding early successes and limitations.Inhibition of p38 MAPK activity leads to cell type-specific effects on the molecular circadian clock and time-dependent reduction of glioma cell invasiveness.Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo.Molecular Targeting of Acid Ceramidase in Glioblastoma: A Review of Its Role, Potential Treatment, and Challenges.Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance.

P2860

Q35743504-4565DFAA-0E7A-49C2-92C0-F443D225F563 Q35999184-2E0824D6-19E2-4E40-A3F2-59BF9FEA3540 Q36235508-FE4FE66A-64B0-49A2-A299-7D2BC7D2B482 Q36277440-0526DDAA-9A5D-4F8C-AA1E-90933BC1B577 Q36391485-39879B8D-F33C-4A91-8254-328C0D8706F7 Q37687470-178C6C40-27F6-43D2-9399-D50CFAEFADD9 Q37701123-0FD1E647-1225-4940-BC0C-FEA5ABC82F01 Q38512587-18B6D160-4018-453D-9097-C3A931309CBA Q38930244-AC94BDF9-830E-4C20-9DE2-DDDA713C5E5D Q38990624-F6E8FAA1-D79D-43D2-8879-C424D3A09BC3 Q39202332-E255DC34-B65F-4BC2-9FE8-9B609904EF81 Q39884714-2B005D10-4833-40E9-B865-2191874DB0A0 Q40327476-0FDD1826-1C31-4A60-B619-433821E0026A Q41186104-AEEAA35B-B653-45DB-ADF0-B3529ACEAA20 Q41311867-1DF097BA-9665-46C6-B098-D6FE0BD99A1B Q42332767-68F95756-D269-4804-9099-E325E6DB4479 Q42685302-3B95AF67-56B0-43A5-B9A3-91D2ED2EF9ED Q47555498-F7D7AFFE-6838-4BB8-A405-A95BF6B99CFE Q47566428-F3CF7338-6275-4BBD-A001-3E984BE66FAD Q48099910-5FD9F603-1791-4234-AE6D-0AFA553F8FBB Q50002230-F6898599-7FF0-4651-909A-058AFC47E0C3 Q52593622-FF236A14-B875-4496-B961-0BA78B89D8B8 Q55663256-A3FD77AE-E6AC-48B4-A3E5-4BF2C12538F4

P2860

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

http://www.wikidata.org/entity/Q33763941

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

@ast

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

@en

type

label

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

@ast

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

@en

prefLabel

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

@ast

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

@en

P1433

Q33763941-E7FC040E-EBF2-4935-A0B4-616C140B3013

P1476

Q33763941-1D49AAEE-26F7-44B4-81A5-31ADCD88B16A

P2093

Q33763941-20BF87DB-9578-4116-A430-985AB12500D5

Q33763941-59E73ADA-CBDE-4CDF-B795-C9EBDCF29B9B

Q33763941-67F33352-9226-4BB9-8CE5-E440FFBD0F7C

Q33763941-81EB909E-99E2-4468-AAFD-00D1AFD50267

Q33763941-A4FAB893-32D9-4ACC-838F-44C80106AD06

P2860

Q33763941-08B4AC2F-9146-46B4-B309-EF6D1037046A

Q33763941-0A7AEA20-1A0D-4D9E-A91F-AB5C50492A2F

Q33763941-25F52722-0EEC-4C38-89F8-A0D812BC48FD

Q33763941-25F7E715-10DA-4126-AA9B-7447F8CF9321

Q33763941-2FCAA893-9B79-4B2A-B324-1598A9559105

Q33763941-38455FD8-73AD-46EE-AF75-918869CF3728

Q33763941-3E40DC58-0C59-4C98-BB80-968EDB262E3C

Q33763941-448D5907-CB10-48FA-AC88-29EDDA026127

Q33763941-4AD196F9-6C0C-416D-8549-8B427058DA96

Q33763941-4B278672-67F8-4379-BFF0-B72C960234F1

P304

Q33763941-8FE8B907-8571-4205-9D31-51F70FE0F67D

P31

Q33763941-9B527A14-B4FD-4E48-916A-8A4A5347D770

P356

Q33763941-DAC1D5E7-691F-4937-B5BB-CAF8B8C1C409

P433

Q33763941-E197FDB0-2E19-4FD0-B1CF-70463262AB60

P478

Q33763941-C2FE94E7-CB63-4877-BC86-8BB6BCDE83C7

P577

Q33763941-DC7283B0-A6BD-477A-87BF-1396602CDDBC

P5875

Q33763941-26573D96-F45A-44F5-A0DC-D2B2E6793FB9

P698

Q33763941-6A2354DA-CD2B-4AC6-8C1B-39A3FF1E1926

P921

Q33763941-5D47E18D-0A94-42B7-B02E-03CBF79168B5

P932

Q33763941-D96BD878-665B-4D1A-9F58-E370E5588DFC

P356

P1433

Current Oncology

P1476

Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

@en

P2093

F Cusano

http://www.w3.org/2001/XMLSchema#string

G A Kline

http://www.w3.org/2001/XMLSchema#string

J Easaw

http://www.w3.org/2001/XMLSchema#string

W Roa

http://www.w3.org/2001/XMLSchema#string

X Kostaras

http://www.w3.org/2001/XMLSchema#string

P2860

2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary].

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

Medical management of brain tumor patients.

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.

Glucocorticoid-induced hyperglycemia.

Drug selection and the management of corticosteroid-related diabetes mellitus.

Corticosteroids in brain cancer patients: benefits and pitfalls.

Defining the impact and contribution of steroids in patients receiving whole-brain irradiation for cerebral metastases.

Dexamethasone therapy in patients with brain tumors--a focus on tapering.

Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.

P304

e493-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.21.1769

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263293657

http://www.w3.org/2001/XMLSchema#string

P698

24940109

http://www.w3.org/2001/XMLSchema#string

P921

P932

4059813

http://www.w3.org/2001/XMLSchema#string